- Report
- July 2026
- 181 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 181 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 211 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 297 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 229 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 196 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 159 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 179 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 173 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 240 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 402 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 392 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 221 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 182 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 195 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 383 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 239 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 238 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 215 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 220 Pages
Global
From €5307EUR$5,850USD£4,574GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more